Korea’s Hugel has entered Malaysia’s growing medical aesthetics market with the launch of its botulinum toxin brand Letybo, teaming up with local partner Venusys Medical Sdn Bhd to pair the rollout with hands-on physician training.

The debut took place at last week’s Aesthetic Medicine & Surgery Conference & Exhibition (AMSC), Malaysia’s largest medical aesthetics meeting. Konstantin Frank, a key opinion leader for Letybo in Europe, presented clinical strategies to improve treatment outcomes.

A separate brand launch event and workshop on Friday at The Zenith Hotel Kuantan drew about 100 Malaysian medical professionals. The session focused on injection techniques combining anatomical knowledge with clinical practice.

Venusys, which operates in both Malaysia and Singapore, distributes medical aesthetics products from multiple global brands and has worked with Hugel on regional expansion.